February 9, 2012

Latop Comp

Bookmark and Share

Company: Rowex Ltd. Legal category: Prescription. GMS. Prohibited in specific sports. Active ingredients: Latanoprost 50mcg/ml, timolol 5mg/ml. Description: Eye drops solution. Presentation: 2.5ml-1, €21.67. Indications: Reduction of intraocular pressure in patients with open angle glaucoma and ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues. Pharmacology: Latanoprost, a prostaglandin F2α analogue, is [...]

Lotemax

Bookmark and Share

Company: Bausch & Lomb (UK) Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Loteprednol etabonate 5mg/ml. Description: Eye drops, suspension. Presentation: 5ml-12. Price on request. Indication: Treatment of post-operative inflammation following ocular surgery. Pharmacology: Loteprednol etabonate is a new class of corticosteroid with potent anti-inflammatory activity designed to be effective at the site of [...]

Valsartan

Bookmark and Share

Company: Niche Generics Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Valsartan 40mg, 80mg, 160mg. Description: Film-coated tablets, scored on one side. 40mg: Yellow-brown, round. 80mg: Pink, round. 160mg: Yellow-brown, oval. All: Can be divided into equal halves. Presentation: 40mg-28, €9.36; 80mg-28, €10.61; 160mg-28, €13.73. Indications: Treatment of essential hypertension in adults (80mg, 160mg), [...]

Zanopro

Bookmark and Share

Company: Clonmel Healthcare Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Latanoprost 50mcg/ml. Description: Eye drops solution. Presentation: 2.5ml, €16.15. Indications: Reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma and ocular hypertension. Reduction of elevated IOP in paediatric patients with elevated IOP and paediatric glaucoma. Pharmacology: Latanoprost, a prostaglandin F2α [...]

Transfer of Quinoderm Cream to Alliance Pharmaceuticals

Bookmark and Share

Alliance Pharmaceuticals Ltd would like to inform you that the marketing and distribution rights of Quinoderm Cream were recently transferred from Ferndale Pharmaceuticals Ltd to Alliance Pharmaceuticals Ltd. From February 2012, all orders should be placed with United Drug Distributors by telephone (01) 4632300 or fax (01) 4632404. If you have any questions regarding this [...]

Salofalk 3g Granule Sachets Available

Bookmark and Share

Salofalk (mesalazine) 3g granule sachets are now available from Dr Falk Pharma UK Ltd. These dual action (gastro-resistant prolonged-release) granules are indicated for the treatment of acute episodes and maintenance of remission of ulcerative colitis. The maximum daily dose can now be taken as one 3g sachet once a day. Salofalk 500mg and 1000mg sachets [...]

Roferon-A 9MIU Temporarily Out of Stock

Bookmark and Share

Roche Products (Ireland) Ltd wishes to inform you that Roferon-A 9MIU solution for injection in pre-filled synringe will stock-out on 1st February 2012. It is envisaged this stock-out will last for a few days and anticipated that supply to the Irish market will resume the week beginning 6th February 2012. Please contact the medical department [...]

Xenical 120mg Hard Capsules Temporarily Out of Stock

Bookmark and Share

Roche Products (Ireland) Ltd wishes to inform you that due to manufacturing issues there is a temporary interruption to the supply chain of Xenical 120mg hard capsules. Roche is working to resolve this situation and to ensure that a steady supply is available to the market as soon as possible. Please contact the medical department [...]

Suggested COPD Algorithm

Bookmark and Share

Adapted from the presentation ‘COPD – Where are we now?’, which took place at the Frontiers in Respiratory Medicine meeting, October 21st, 2011. MIMS Ireland Copyright®

Update on COPD

Bookmark and Share

Prevalence Moderate and Severe COPD affects one in 10 people The prevalence of COPD is increasing in Ireland, and COPD is expected to be the third cause of death by 2020. BOLD, a worldwide study including close to 10,000 participants, aimed to measure the prevalence of COPD, its risk factors and their variation across countries [...]

« Previous Page
Next Page »